12th Dec 2006 12:06
AGI Therapeutics plc12 December 2006 AGI Therapeutics plc ("AGI" or the "Company") Holdings(s) in Company AGI was notified today that, following a sale of 250,000 ordinary shares of€0.01 each, Gartmore Investment Limited, Gartmore Fund Managers and GartmoreGlobal Partners have a holding of 4.75% of the issued share capital of theCompany. Contact Information AGI TherapeuticsDavid G. Kelly, Chief Financial OfficerTel: +353 1 449 3254 12 December 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai